Decreased dopamine D2 receptor binding in essential blepharospasm

被引:23
|
作者
Horie, C. [1 ,2 ]
Suzuki, Y. [1 ,2 ]
Kiyosawa, M. [2 ]
Mochizuki, M. [2 ]
Wakakura, M. [3 ]
Oda, K. [1 ]
Ishiwata, K. [1 ]
Ishii, K. [1 ]
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan
[3] Inouye Eye Hosp, Tokyo, Japan
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 01期
关键词
dopamine D-2 receptor; essential blepharospasm; positron emission tomography; C-11]raclopride; DOPA-RESPONSIVE DYSTONIA; POSITRON-EMISSION-TOMOGRAPHY; BASAL GANGLIA; C-11; RACLOPRIDE; FOCAL DYSTONIA; D2; RECEPTORS; INHIBITION; PET; MUTATION; CARRIERS;
D O I
10.1111/j.1600-0404.2008.01053.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to investigate whether dopamine D-2 receptor binding was altered in the striatum of essential blepharospasm patients. Striatal dopamine D-2 receptor binding was measured with positron emission tomography and [C-11]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls. The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group. This study indicates decreased dopamine D-2 receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D-2 receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [21] Effects of deep brain stimulation on dopamine D2 receptor binding in patients with treatment-refractory depression
    Wang, Fang
    Xin, Mei
    Li, Xuefei
    Li, Lianghua
    Wang, Cheng
    Dai, Lulin
    Zheng, Chaojie
    Cao, Kaiyi
    Yang, Xuefei
    Ge, Qi
    Li, Bolun
    Wang, Tao
    Zhan, Shikun
    Li, Dianyou
    Zhang, Xiaoxiao
    Paerhati, Halimureti
    Zhou, Yun
    Liu, Jianjun
    Sun, Bomin
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 356 : 672 - 680
  • [22] Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects
    Hagelberg, N
    Aalto, S
    Kajander, J
    Oikonen, V
    Hinkka, S
    Någren, K
    Hietala, J
    Scheinin, H
    PAIN, 2004, 109 (1-2) : 86 - 93
  • [23] Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans
    Verhoeff N.P.L.G.
    Tauscher J.
    Jones C.
    Hussey D.
    Lee M.
    Papatheodorou G.
    Wilson A.A.
    Houle S.
    Kapur S.
    Molecular Psychiatry, 2002, 7 (3) : 322 - 328
  • [24] Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans
    Verhoeff, NPLG
    Hussey, D
    Lee, M
    Tauscher, J
    Papatheodorou, G
    Wilson, AA
    Houle, S
    Kapur, S
    MOLECULAR PSYCHIATRY, 2002, 7 (03) : 322 - 328
  • [25] Dopamine D2 receptor availability is associated with subjective responses to alcohol
    Yoder, KK
    Kareken, DA
    Seyoum, RA
    O'Connor, SJ
    Wang, CZ
    Zheng, QH
    Mock, B
    Morris, ED
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (06) : 965 - 970
  • [26] Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
    Ryoo, HL
    Pierrotti, D
    Joyce, JN
    MOVEMENT DISORDERS, 1998, 13 (05) : 788 - 797
  • [27] Relation among dopamine D2 receptor binding, obesity and personality in normal human subjects
    Yasuno, F
    Suhara, T
    Sudo, Y
    Yamamoto, M
    Inoue, M
    Okubo, Y
    Suzuki, K
    NEUROSCIENCE LETTERS, 2001, 300 (01) : 59 - 61
  • [28] New Dopamine D2 Receptor Agonist, [3H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo
    Subburaju, Sivan
    Sromek, Anna W.
    Seeman, Philip
    Neumeyer, John L.
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (06): : 1283 - 1289
  • [29] Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride
    Hirvonen, J
    Aalto, S
    Lumme, V
    Någren, K
    Kajander, J
    Vilkman, H
    Hagelberg, N
    Oikonen, V
    Hietala, J
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (12) : 1207 - 1214
  • [30] The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI
    Wagner, Amy K.
    Scanlon, Joelle M.
    Becker, Carl R.
    Ritter, Anne C.
    Niyonkuru, Christian
    Dixon, Clifton E.
    Conley, Yvette P.
    Price, Julie C.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (08): : 1328 - 1339